GB1512258A - 18-methyl-19-nor-20-keto-pregnanes and process for their manufacture - Google Patents
18-methyl-19-nor-20-keto-pregnanes and process for their manufactureInfo
- Publication number
- GB1512258A GB1512258A GB32477/75A GB3247775A GB1512258A GB 1512258 A GB1512258 A GB 1512258A GB 32477/75 A GB32477/75 A GB 32477/75A GB 3247775 A GB3247775 A GB 3247775A GB 1512258 A GB1512258 A GB 1512258A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methyl
- steroids
- acetoxy
- dione
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 150000003431 steroids Chemical class 0.000 abstract 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 2
- XMRPGKVKISIQBV-UHFFFAOYSA-N (+-)-5- Pregnane-3,20-dione Natural products C1CC2CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 XMRPGKVKISIQBV-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 1
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 230000002082 anti-convulsion Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2438020A DE2438020A1 (de) | 1974-08-05 | 1974-08-05 | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1512258A true GB1512258A (en) | 1978-05-24 |
Family
ID=5922668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB32477/75A Expired GB1512258A (en) | 1974-08-05 | 1975-08-04 | 18-methyl-19-nor-20-keto-pregnanes and process for their manufacture |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4029777A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5141347A (cg-RX-API-DMAC10.html) |
| AT (1) | AT345998B (cg-RX-API-DMAC10.html) |
| BE (1) | BE832124A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1037027A (cg-RX-API-DMAC10.html) |
| CH (1) | CH611910A5 (cg-RX-API-DMAC10.html) |
| CS (2) | CS175498B2 (cg-RX-API-DMAC10.html) |
| DD (1) | DD120192A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2438020A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK136369C (cg-RX-API-DMAC10.html) |
| ES (1) | ES439720A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2281123A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1512258A (cg-RX-API-DMAC10.html) |
| HU (1) | HU171684B (cg-RX-API-DMAC10.html) |
| IL (1) | IL47770A (cg-RX-API-DMAC10.html) |
| NL (1) | NL7509326A (cg-RX-API-DMAC10.html) |
| SE (1) | SE404804B (cg-RX-API-DMAC10.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61144199A (ja) * | 1984-12-18 | 1986-07-01 | Pioneer Electronic Corp | スピ−カ用紙製振動部材の製造方法 |
| EP0382790A4 (en) * | 1987-08-25 | 1991-03-27 | Kelvin W. Gee | Compositions and methods for alleviating stress, anxiety and seizure activity |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| BR112015026380A8 (pt) | 2013-04-17 | 2019-12-31 | Sage Therapeutics Inc | esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| CN117304245A (zh) | 2013-04-17 | 2023-12-29 | 萨奇治疗股份有限公司 | 刺激神经活性的19-去甲类固醇及其使用方法 |
| AU2014290400B2 (en) | 2013-07-19 | 2019-12-05 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EP3488852B1 (en) | 2013-08-23 | 2020-10-28 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| CN117024502A (zh) | 2014-10-16 | 2023-11-10 | 萨奇治疗股份有限公司 | 靶向cns障碍的组合物和方法 |
| AU2015331597B2 (en) | 2014-10-16 | 2020-04-30 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| EP3719029A1 (en) | 2014-11-27 | 2020-10-07 | Sage Therapeutics, Inc. | Compositions for inducing sedation |
| DK3250210T3 (da) | 2015-01-26 | 2021-03-08 | Sage Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser |
| WO2016134301A2 (en) | 2015-02-20 | 2016-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| NZ749664A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| JP7065825B2 (ja) | 2016-07-11 | 2022-05-12 | セージ セラピューティクス， インコーポレイテッド | Ｃ７、ｃ１２、およびｃ１６置換神経刺激性ステロイドおよびそれらの使用方法 |
| JP7382326B2 (ja) * | 2017-12-22 | 2023-11-16 | セージ セラピューティクス， インコーポレイテッド | Ｃｎｓ障害の処置のための組成物および方法 |
| AR119047A1 (es) | 2019-05-31 | 2021-11-17 | Sage Therapeutics Inc | Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791196A (fr) * | 1971-11-11 | 1973-05-10 | Glaxo Lab Ltd | Nouveaux steroides, leur procede de preparation et leurs applications |
| GB1409239A (en) * | 1971-11-11 | 1975-10-08 | Glaxo Lab Ltd | Process for the preparation of 3alpha-hydroxy-5alpha-steroids |
-
1974
- 1974-08-05 DE DE2438020A patent/DE2438020A1/de not_active Withdrawn
-
1975
- 1975-07-22 CS CS5170A patent/CS175498B2/cs unknown
- 1975-07-22 CS CS215A patent/CS175500B2/cs unknown
- 1975-07-23 IL IL47770A patent/IL47770A/xx unknown
- 1975-07-24 ES ES439720A patent/ES439720A1/es not_active Expired
- 1975-07-29 DK DK344475A patent/DK136369C/da active
- 1975-08-01 DD DD187639A patent/DD120192A5/xx unknown
- 1975-08-01 AT AT600475A patent/AT345998B/de not_active IP Right Cessation
- 1975-08-01 CA CA232,730A patent/CA1037027A/en not_active Expired
- 1975-08-04 FR FR7524225A patent/FR2281123A1/fr not_active Withdrawn
- 1975-08-04 HU HU75SCHE529A patent/HU171684B/hu unknown
- 1975-08-04 GB GB32477/75A patent/GB1512258A/en not_active Expired
- 1975-08-04 SE SE7508777A patent/SE404804B/xx unknown
- 1975-08-05 JP JP50095322A patent/JPS5141347A/ja active Pending
- 1975-08-05 NL NL7509326A patent/NL7509326A/xx not_active Application Discontinuation
- 1975-08-05 CH CH1020975A patent/CH611910A5/xx not_active IP Right Cessation
- 1975-08-05 US US05/602,098 patent/US4029777A/en not_active Expired - Lifetime
- 1975-08-05 BE BE158941A patent/BE832124A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK344475A (da) | 1976-02-06 |
| NL7509326A (nl) | 1976-02-09 |
| IL47770A0 (en) | 1975-10-15 |
| DD120192A5 (cg-RX-API-DMAC10.html) | 1976-06-05 |
| CS175500B2 (cg-RX-API-DMAC10.html) | 1977-05-31 |
| DK136369B (da) | 1977-10-03 |
| IL47770A (en) | 1978-10-31 |
| CH611910A5 (cg-RX-API-DMAC10.html) | 1979-06-29 |
| AT345998B (de) | 1978-10-10 |
| BE832124A (fr) | 1976-02-05 |
| CA1037027A (en) | 1978-08-22 |
| CS175498B2 (cg-RX-API-DMAC10.html) | 1977-05-31 |
| SE404804B (sv) | 1978-10-30 |
| ES439720A1 (es) | 1977-03-01 |
| JPS5141347A (en) | 1976-04-07 |
| FR2281123A1 (fr) | 1976-03-05 |
| ATA600475A (de) | 1978-02-15 |
| DE2438020A1 (de) | 1976-02-26 |
| HU171684B (hu) | 1978-02-28 |
| AU8351575A (en) | 1977-02-03 |
| US4029777A (en) | 1977-06-14 |
| SE7508777L (sv) | 1976-02-06 |
| DK136369C (da) | 1978-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1512258A (en) | 18-methyl-19-nor-20-keto-pregnanes and process for their manufacture | |
| GB1494097A (en) | D-homo-20-keto-pregnanes | |
| GB1447247A (en) | Beta-3-oxo-7alpha-acylthio-17beta-hydroxy-4-androsten- or estren 17alpha-yl-propionic acid y-lactones and intermediates in the production thereof | |
| GB1530615A (en) | 15,16-methylene-steroids of the pregnane series | |
| GB1383334A (en) | 15alpha,16alpha-methylene-steroids | |
| GB1213118A (en) | PROCESS FOR PREPARING 9alpha-FLUORO-16-METHYLENE-PREDNISOLONE OR PREDNISONE, AND 21-ESTERS THEREOF | |
| GB1472119A (en) | Electrocatalytic hydrogenation process | |
| GB1343975A (en) | 16beta-difluoromethyl and 16-fifluoromethylene steroids and processes for their preparation | |
| GB1350397A (en) | D-homosteroid imides and a process for the preparation thereof | |
| GB1192824A (en) | Improvements in or relating to 6,7-Methylene and -Halomethylene Steroids | |
| ES388852A1 (es) | Un metodo para producir nuevos compuestos de 16-metilen-9 beta, 10 alfa-esteroide. | |
| GB1097656A (en) | A process for the manufacture of steroids of the pregnane series | |
| GB1164705A (en) | Preparation of Delta<7>-Dehydro Steroids | |
| GB1237483A (en) | MICROBIAL REDUCTION OF Delta<5> STEROIDS | |
| GB1174360A (en) | 6,16-Dimethyl-21-Fluoro-Steriods of the Pregnane Series. | |
| GB1302903A (cg-RX-API-DMAC10.html) | ||
| GB1303008A (cg-RX-API-DMAC10.html) | ||
| GB1314265A (en) | 1alpha,2alpha 6beta,7beta-dimethylene-steroids | |
| AT230027B (de) | Verfahren zur Herstellung von 4-Methyl-3-oxo-Δ<4>-steroiden | |
| AT274257B (de) | Verfahren zur Herstellung von 17-oxygenierten 3-Oxo-Δ<4,9,11>-trienen der 19-Nor-androstanreihe | |
| GB1250394A (cg-RX-API-DMAC10.html) | ||
| GB1214004A (en) | 7-dehydro steroids | |
| GB980253A (en) | Process for the manufacture of 18-substituted steroids | |
| GB1363454A (en) | 9-methyl-steroids | |
| GB1387698A (en) | 6alpha,9alpha-difluorosteroids of the pregnane series and processes for their manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |